Recent Posts

• Noble Capital Markets and Channelchek to Host Investor Forum C-Suite Interviews During Prestigious 16th Annual World Stem Cell Summit
• Amritha Jaishankar, Ph.D. Appointed As New Executive Director of Maryland Stem Cell Research Fund
• Human mesenchymal stem cells show promise in treating chronic lung infections
• Longeveron Selected to Present at the 2021 World Stem Cell Summit Dr. Joshua Hare, Longeveron’s Chief Science Officer, to present during this year’s Longevity Session
• Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury
• Advancing the Development of Safe and Effective Regenerative Medicine Products
• Clinical trial assesses stem cells’ ability to prevent major cause of preemie deaths
• Fat grafts enhanced with ADSCs show promise in treating facial scleroderma
• Registration open for the VIRTUAL World Stem Cell Summit and Regenerative Medicine Essentials Course June 14-18, 2021
• Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami
• Stem cell therapy research could help patients with non-healing diabetic foot ulcers
• Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19
• Riccardo Gottardi, PhD
• Antioxidant-primed stem cells show promise in repairing bone damaged by radiation
• Longeveron’s Lomecel-B™ Approved by FDA for Compassionate Use for the Treatment of Child with Hypoplastic Left Heart Syndrome (HLHS)